Search Page

1

Cite

Share

Novel Aspects of Extracellular Vesicles as Mediators of Cancer-Associated Thrombosis.

Almeida VH, Rondon AMR, Gomes T, Monteiro RQ. Almeida VH, et al. Among authors: rondon amr. Cells. 2019 Jul 13;8(7):716. doi: 10.3390/cells8070716. Cells. 2019. PMID: 31337034 Free PMC article. Review.

Cite

Share

2

Cite

Share

Role of Tissue Factor in Tumor Progression and Cancer-Associated Thrombosis.

Rondon AMR, Kroone C, Kapteijn MY, Versteeg HH, Buijs JT. Rondon AMR, et al. Semin Thromb Hemost. 2019 Jun;45(4):396-412. doi: 10.1055/s-0039-1687895. Epub 2019 May 16. Semin Thromb Hemost. 2019. PMID: 31096312 Review.

Cite

Share

3

Cite

Share

De-Palmitoylation of Tissue Factor Regulates Its Activity, Phosphorylation and Cellular Functions.

Ettelaie C, Featherby S, Rondon AMR, Greenman J, Versteeg HH, Maraveyas A. Ettelaie C, et al. Among authors: rondon amr. Cancers (Basel). 2021 Jul 30;13(15):3837. doi: 10.3390/cancers13153837. Cancers (Basel). 2021. PMID: 34359738 Free PMC article.

Cite

Share

4

Cite

Share

Factor VIIa Regulates the Level of Cell-Surface Tissue Factor through Separate but Cooperative Mechanisms.

Madkhali Y, Rondon AMR, Featherby S, Maraveyas A, Greenman J, Ettelaie C. Madkhali Y, et al. Among authors: rondon amr. Cancers (Basel). 2021 Jul 23;13(15):3718. doi: 10.3390/cancers13153718. Cancers (Basel). 2021. PMID: 34359618 Free PMC article.

Cite

Share

5

Cite

Share

Tissue factor mediates microvesicles shedding from MDA-MB-231 breast cancer cells.

Rondon AMR, de Almeida VH, Gomes T, Verçoza BRF, Carvalho RS, König S, Rodrigues JCF, Mermelstein CDS, Versteeg HH, Monteiro RQ. Rondon AMR, et al. Biochem Biophys Res Commun. 2018 Jul 7;502(1):137-144. doi: 10.1016/j.bbrc.2018.05.136. Epub 2018 May 24. Biochem Biophys Res Commun. 2018. PMID: 29787758 Free article.

Cite

Share

6

Cite

Share

Evaluation of Proton-Induced DNA Damage in 3D-Engineered Glioblastoma Microenvironments.

Akolawala Q, Rovituso M, Versteeg HH, Rondon AMR, Accardo A. Akolawala Q, et al. Among authors: rondon amr. ACS Appl Mater Interfaces. 2022 Apr 20;14(18):20778-89. doi: 10.1021/acsami.2c03706. Online ahead of print. ACS Appl Mater Interfaces. 2022. PMID: 35442634 Free PMC article.

Cite

Share

7

Cite

Share

IL-1β Blockade Attenuates Thrombosis in a Neutrophil Extracellular Trap-Dependent Breast Cancer Model.

Gomes T, Várady CBS, Lourenço AL, Mizurini DM, Rondon AMR, Leal AC, Gonçalves BS, Bou-Habib DC, Medei E, Monteiro RQ. Gomes T, et al. Among authors: rondon amr. Front Immunol. 2019 Sep 4;10:2088. doi: 10.3389/fimmu.2019.02088. eCollection 2019. Front Immunol. 2019. PMID: 31552036 Free PMC article.

Cite

Share

8

Cite

Share

Protease-activated receptor 2 (PAR2) upregulates granulocyte colony stimulating factor (G-CSF) expression in breast cancer cells.

Carvalho É, Hugo de Almeida V, Rondon AMR, Possik PA, Viola JPB, Monteiro RQ. Carvalho É, et al. Among authors: rondon amr. Biochem Biophys Res Commun. 2018 Sep 26;504(1):270-276. doi: 10.1016/j.bbrc.2018.08.169. Epub 2018 Aug 30. Biochem Biophys Res Commun. 2018. PMID: 30172372 Free article.

Cite

Share

9

Cite

Share

Breast-cancer extracellular vesicles induce platelet activation and aggregation by tissue factor-independent and -dependent mechanisms.

Gomes FG, Sandim V, Almeida VH, Rondon AMR, Succar BB, Hottz ED, Leal AC, Verçoza BRF, Rodrigues JCF, Bozza PT, Zingali RB, Monteiro RQ. Gomes FG, et al. Among authors: rondon amr. Thromb Res. 2017 Nov;159:24-32. doi: 10.1016/j.thromres.2017.09.019. Epub 2017 Sep 21. Thromb Res. 2017. PMID: 28950217

Cite

Share

10

Cite

Share

Positive crosstalk between EGFR and the TF-PAR2 pathway mediates resistance to cisplatin and poor survival in cervical cancer.

Hugo de Almeida V, Guimarães IDS, Almendra LR, Rondon AMR, Tilli TM, de Melo AC, Sternberg C, Monteiro RQ. Hugo de Almeida V, et al. Among authors: rondon amr. Oncotarget. 2018 Jul 17;9(55):30594-30609. doi: 10.18632/oncotarget.25748. eCollection 2018 Jul 17. Oncotarget. 2018. PMID: 30093972 Free PMC article.

Cite

Share